Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
Clinical trial NCT00622505 · COMPLETED
Trial details
- NCT number
- NCT00622505
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-07
- Primary completion
- 2012-04-03
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.